•
Sep 30, 2022

Cocrystal Pharma Q3 2022 Earnings Report

EPS
-$0.7
Previous year: -$0.48
+45.8%
Cash and Equivalents
$42.1M
Previous year: $61.6M
-31.7%
Free Cash Flow
-$8.97M
Previous year: -$5.41M
+65.9%
Total Assets
$45.6M
Previous year: $82.6M
-44.7%

Cocrystal Pharma

Cocrystal Pharma